on February 24, 2005
Published online before print February 24, 2005, doi: 10.1161/01.ATV.0000160612.18065.29
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 23, 2004
Accepted on February 9, 2005
Role of Insulin Resistance in Familial Combined Hyperlipidemia
M. J. Veerkamp ;
From the Department of Medicine, Division of General Internal Medicine, University Medical Center Nijmegen, The Netherlands.
* To whom correspondence should be addressed. E-mail: j.degraaf{at}aig.umcn.nl.
Objective--Insulin resistance is associated with increased triglyceride levels, low high-density lipoprotein cholesterol, small dense low-density lipoprotein (LDL), and increased apolipoprotein B (apoB) levels, all characteristics of familial combined hyperlipidemia (FCH). Therefore, we explored the role of insulin resistance in FCH lipid phenotype expression.
Methods and Results--FCH was defined by traditional diagnostic criteria including plasma total cholesterol or triglyceride levels >90th percentile. Insulin resistance was assessed by the Homeostasis Model Assessment (HOMA) index. In total, 132 subjects with FCH, 350 normolipidemic relatives, and 81 spouses who referenced as controls were studied. FCH subjects were significantly more insulin resistant compared with controls and normolipidemic relatives (HOMA index 2.9 [95% CI, 2.6 to 3.2], 2.2 [95% CI, 2.0 to 2.5], and 2.0 [95% CI, 1.9 to 2.2], respectively), even after correction for sex, age, and body mass index (BMI). The degree of insulin resistance was associated with the lipid phenotype expression, and a change in insulin-resistant state was associated with a change in lipid phenotype expression over 5 years. For any level of insulin resistance and degree of obesity, FCH subjects had increased levels of apoB and more small dense LDL compared with controls.
Conclusion--Insulin resistance is a characteristic feature of FCH, which is not fully explained by their increased BMI and is associated with (change in) lipid phenotype expression. Furthermore, our results support the concept of genetic origin of high apoB and small dense LDL in FCH, which is modulated by insulin resistance and obesity.
This article has been cited by other articles:
 |
|
 |
|
  A. L. Garcia-Otin, M. Cofan, M. Junyent, D. Recalde, A. Cenarro, M. Pocovi, E. Ros, and F. Civeira Increased Intestinal Cholesterol Absorption in Autosomal Dominant Hypercholesterolemia and No Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3667 - 3673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Coenen, M. L. Gruen, A. Chait, and A. H. Hasty Diet-Induced Increases in Adiposity, but Not Plasma Lipids, Promote Macrophage Infiltration Into White Adipose Tissue Diabetes, March 1, 2007; 56(3): 564 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Asato, K. Katsuren, T. Ohshiro, K. Kikawa, T. Shimabukuro, and T. Ohta Relationship Between Lipid Abnormalities and Insulin Resistance in Japanese School Children Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2781 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. van der Vleuten, L. J. H. van Tits, M. den Heijer, H. Lemmers, A. F. H. Stalenhoef, and J. de Graaf Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile J. Lipid Res., November 1, 2005; 46(11): 2398 - 2404. [Abstract] [Full Text] [PDF]
|
|